Multiplexing of SMA, SCID and XLA screening can now be done in one assay utilizing Real-Time PCR technology, without increasing daily hands-on workload and complexity. This will provide a future-proof solution for cost-efficiently obtaining additional disorder information.
Combination of DNA extraction, multiplexing and automation allows maximum efficiency in workflow. Analytes are quantified using innovative analysis method without calibrators, saving more room for your samples. For maximum flexibility and throughput, as well as for minimum hands-on time, liquid handling can be used both for DNA Extraction and for PCR setup in the Eonis™ platform.